about
Lysine acetylation: codified crosstalk with other posttranslational modificationsMechanisms of Histone Deacetylase Inhibitor-Regulated Gene Expression in Cancer CellsExacerbated innate host response to SARS-CoV in aged non-human primatesNatural Compound Histone Deacetylase Inhibitors (HDACi): Synergy with Inflammatory Signaling Pathway Modulators and Clinical Applications in CancerCombined genetic and epigenetic interferences with interferon signaling expose prostate cancer cells to viral infectionBRMS1 suppresses lung cancer metastases through an E3 ligase function on histone acetyltransferase p300.Interferon induction and function at the mucosal surface.Interferon regulatory factor-8 is important for histone deacetylase inhibitor-mediated antitumor activity.Regulation of signal transducer and activator of transcription 3 enhanceosome formation by apurinic/apyrimidinic endonuclease 1 in hepatic acute phase response.Survivin, a molecular target for therapeutic interventions in squamous cell carcinoma.Cooperativity of the MUC1 oncoprotein and STAT1 pathway in poor prognosis human breast cancer.Variation in transcription factor binding among humans.Plant HDAC inhibitor chrysin arrest cell growth and induce p21WAF1 by altering chromatin of STAT response element in A375 cellsFunctional characterization of novel mutations affecting survivin (BIRC5)-mediated therapy resistance in head and neck cancer patients.The clinical and biological significance of STAT1 in esophageal squamous cell carcinoma.A novel form of human STAT1 deficiency impairing early but not late responses to interferons.Suppression of interferon lambda signaling by SOCS-1 results in their excessive production during influenza virus infectionHDAC4-regulated STAT1 activation mediates platinum resistance in ovarian cancer.STAT1 signaling is not regulated by a phosphorylation-acetylation switchThe two faces of interferon-γ in cancer.Induction of inducible NO synthase in bystander human T cells increases allogeneic responses in the vasculatureNonhistone protein acetylation as cancer therapy targets.Targeting the interleukin-6/Jak/stat pathway in human malignanciesRegulation of STAT signaling by acetylation.STAT1 modification improves therapeutic effects of interferons on lung cancer cellsDeubiquitinase USP2a Sustains Interferons Antiviral Activity by Restricting Ubiquitination of Activated STAT1 in the Nucleus.Natural chalcones as dual inhibitors of HDACs and NF-κB.Inhibiting autophagy potentiates the anticancer activity of IFN1@/IFNα in chronic myeloid leukemia cellsDevelopment of histone deacetylase inhibitors for cancer treatment.Requirement of histone deacetylase1 (HDAC1) in signal transducer and activator of transcription 3 (STAT3) nucleocytoplasmic distribution.Inhibition of the proliferation of acquired aromatase inhibitor-resistant breast cancer cells by histone deacetylase inhibitor LBH589 (panobinostat).Site-specific acetylation of the proteasome activator REGγ directs its heptameric structure and functions.p16INK4a deficiency promotes IL-4-induced polarization and inhibits proinflammatory signaling in macrophages.Inteferons pen the JAK-STAT pathway.Histone deacetylases: salesmen and customers in the post-translational modification market.Cross-regulation of signaling pathways by interferon-gamma: implications for immune responses and autoimmune diseases.Histone deacetylase inhibitors modulate interleukin 6-dependent CD4+ T cell polarization in vitro and in vivoHistone deacetylases and the immunological network: implications in cancer and inflammation.Modulation of gene expression regulated by the transcription factor NF-κB/RelAHistone deacetylase inhibitors: potential targets responsible for their anti-cancer effect.
P2860
Q24644959-A42E7FE4-D797-43FA-A253-5FA39FD9A33CQ27015931-ECB973C8-8B37-45B2-8CF2-B84AD42203C9Q27315954-C285CFE0-9011-4DB0-83F3-4EB7344AEAF2Q28073020-D4EE3D0A-C331-4412-B159-412E9BE59C42Q28817152-9E0AFAFE-4E1A-444A-9B1C-EAE5258ACE95Q30414771-620FCA50-3125-4AD2-AEFA-44039BBB2654Q30661545-4068A93A-732D-4A57-96D0-1C119D543649Q31101656-A2AD40E4-F7E0-484E-A8BB-89DBA2B73F15Q33634271-A3C5CEC5-8FDB-4AA2-99F3-FCA60336E6CAQ33634679-E9D77222-44A6-42B7-A077-DA8283F5EC2AQ33647653-1FDC5E4E-8D9C-448B-8DED-911D47CA4879Q34105133-48DE56E7-4697-4570-9E53-B6242BA85835Q34271529-4E475C71-4022-4C86-BDD3-9A4E7523AEE1Q34480741-4BEEB56E-719A-46DB-8B87-997D0A10FB1AQ34517533-735BA5E3-BB6F-4976-8EDA-39480EFE4903Q34541567-DE14AF97-A1CB-42FB-98A9-7DACB9BB1425Q35082203-41606408-C044-439C-905B-559EEC102C2AQ35087685-88C388EC-6674-4729-ACFA-FF784F24C773Q35096677-17D6FCCF-86E0-4054-8A97-A81F111C2463Q35269015-F62E92F6-1344-4282-886C-0570A6D59028Q35611554-C0C1819E-7926-4EFE-AF84-272435749AE9Q35739676-ABF2CDF4-BD29-4ED1-8F1E-CAF33E3410F9Q35925127-B3BB2B4C-C25B-43ED-AD2C-BFDF36033C01Q35998100-DCA34429-C73B-4D8F-9B92-FAEB9151B7B6Q36035457-E4E5B99D-D803-46F2-ACF3-00D41232F5AFQ36081827-D3EA462F-3517-488B-B29D-DA6DCC27DEE3Q36642705-E7AF7F7D-B144-46D3-A768-CF81667C4349Q36662342-AC545588-1433-4F0A-93BE-885E8046790DQ36788512-B9D6F29E-168B-40D5-8B19-72DA6FB48C4AQ36798717-F6CF7E95-2D94-475C-B504-63024381C03EQ36799721-C19DEE06-0DDE-4EFF-8853-9027E1E56888Q36910088-9D3F67AC-2E6E-4EB4-87BA-2D27F689D06BQ36916423-3319D531-53F9-4F05-8AD7-4220D4255932Q37259013-153D2631-817D-4DC4-8C1D-D2F32C0A5E3FQ37389553-FF6AA555-8BA0-4107-8B7F-6084122AEF80Q37414046-0A022C05-D728-482E-A17F-BD7484C10B74Q37608561-5B327962-D36F-4A02-AA35-6F30AE7BB41EQ37621256-20446943-8D22-444C-8114-8665FF4BC273Q37727621-414C0043-9523-40D9-B9FA-ED96B62E088EQ37821337-E604DF00-292F-4AF3-B78A-6B1A33FB31D6
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Acetylation of Stat1 modulates NF-kappaB activity
@en
type
label
Acetylation of Stat1 modulates NF-kappaB activity
@en
prefLabel
Acetylation of Stat1 modulates NF-kappaB activity
@en
P2093
P2860
P50
P356
P1433
P1476
Acetylation of Stat1 modulates NF-kappaB activity
@en
P2093
Daniela Baus
Edith Pfitzner
Elke Jäger
Manuel Grez
Stefan Stein
Thorsten Heinzel
P2860
P304
P356
10.1101/GAD.364306
P577
2006-02-01T00:00:00Z